Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Cronos Group Inc. CRON, +15.55% shares jumped 14% on Tuesday after the cannabis company's first-quarter revenue of $25 million beat the analyst estimate by $1 million. Raymond James analyst Rahul Sarugaser reiterated an outperform rating on the stock and said Cronos also reported a better-than-expected adjusted Ebitda loss of $18.9 million, against a target for an adjusted Ebitda loss of $27.5 million.

Cronos shares rally as investors cheer latest results

Cronos Group Inc. (NASDAQ:CRON ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Shayne Laidlaw - IR Mike Gorenstein - Chairman, President and CEO Bob Madore - CFO Conference Call Participants Michael Frieden - Raymond James John Zamparo - CIBC Andrew Carter - Stifel Matt Bottomley - Canaccord Gaurav Jain - Barclays Operator Good morning, my name is Amanda, and I will be your conference operator today. I would like to welcome everyone to Cronos Group 2022 First Quarter Earnings Conference Call.

Cronos Group Inc. (CRON) CEO Mike Gorenstein on Q1 2022 Results - Earnings Call Transcript

Cronos (CRON) delivered earnings and revenue surprises of 0% and 7.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Cronos Group (CRON) Reports Q1 Loss, Tops Revenue Estimates

Revenue gains are driven by growth of the Israeli medical market and Canadian adult-use market.

Cronos Group Doubles Sales, Thanks to Growth in Canada and Israel

Cronos Group CRON, -4.39% said Tuesday its first-quarter net loss narrowed to $16.42 million, or 9 cents a share, from a loss of $146.2 million, or 44 cents a share, in the year-ago quarter. Revenue doubled to $25.03 million from $12.61 million.

Cannabis company Cronos Group doubles revenue, beats analyst target

Consolidated net revenue increased by 99% year-over-year to $25.0 million in Q1 2022

Cronos Group Reports 2022 First Quarter Results

Hut 8 Mining Corp

Kinross Gold

Transocean

When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. The post 4 Stocks Under $10 That Could Double By December 2022 appeared first on InvestorPlace.

4 Stocks Under $10 That Could Double By December 2022

Canopy Growth

Tilray Brands

3 Canadian Marijuana Stocks To Watch This Upcoming Week The post 3 Canadian Marijuana Stocks To Watch Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Watch Next Week

AMC Entertainment

Hecla Mining

Li Auto Inc.

Peloton

All three major U.S. equity indexes were slammed Thursday, dropping by 3% to 5%. In the first hour of trading, all the previous day's gains were wiped out.

Earnings Previews: AMC Entertainment, Cronos, Hecla Mining, Li Auto, Peloton

TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2022 Annual Meeting of Shareholders on Thursday, June 23, 2022, at 11:00 a.m. ET.

Cronos Group Inc. to Hold Virtual 2022 Annual Meeting of Shareholders

These top cannabis stocks are worth buying after a deep correction, as they can rally on hopes of more states legalizing marijuana. The post 3 Top Cannabis Stocks to Buy as State Legalization Grows appeared first on InvestorPlace.

3 Top Cannabis Stocks to Buy as State Legalization Grows

New York, New York--(Newsfile Corp. - April 28, 2022) - Sphynx Labs continues to integrate other Blockchains into its Ecosystem, and this time, they are on Cronos Network. The Team of Sphynx Labs will introduce its token called SPHYNX to be traded on Cronos.Sphynx Labs on CronosTo view an enhanced version of this graphic, please visit:

Cronos is Welcoming Sphynx Labs to its Network

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 first quarter earnings conference call on Tuesday, May 10, 2022 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2022 First Quarter Earnings Conference Call on May 10, 2022

OrganiGram Holdings Inc.

SNDL Inc.

Are Penny Stocks The Best Trades Right Now? The post Trending Marijuana Penny Stocks To Buy? 3 On The Nasdaq To Watch In May appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Trending Marijuana Penny Stocks To Buy? 3 On The Nasdaq To Watch In May

Aurora Cannabis

4/20 is a time to celebrate the cannabis plant and industry but also a time to reflect on how much further we still need to go. Reginald Stanfield started JustinCredible Cultivation, the first non-equity, Black-Owned Cannabis Cultivation in Massachusetts.

Cultivating Change In Cannabis (Podcast Transcript)

Cultivating Change In Cannabis

The move would open up the New York metro region to the cannabis industry.

Legal Cannabis Sales to Begin April 21 in New Jersey. What It Means for Weed Stocks.

Cannabis Stocks: Near-Term Headwinds Don't Matter Much (Podcast Transcript)

We Need To Talk About Cannabis (Podcast Transcript)

NEW YORK--(BUSINESS WIRE)-- #CRON--WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rose

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cronos Group Inc. Investors to Inquire About Class Action Investigation – CRON

Amplify Alternative Harvest ETF

MedMen Enterprises Inc.

We hoped cannabis companies could turn huge demand into huge gains, but it's become clear that they can't. We're bearish on cannabis stocks.

🌱 Cannabis Stocks Are Booming, but Others Are WAY Better Buys

Village Farms International

These Pot Stocks Should Be On Your Watchlist This Week The post Top Canadian Marijuana Stocks To Buy? 3 To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Buy? 3 To Watch Right Now

Shares of many cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ: CRON), Sundial Growers Inc (NASDAQ: SNDL) and Tilray Inc (NASDAQ: TLRY), are all trading lower due to profit-taking from last week's rally amid.

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Falling

Sundial and Tilray are up about 50% but the gains may just be temporary.

Cannabis Stocks Are Surging Ahead Of House Vote On Marijuana Legalization Next Week

Cronos (formerly Crypto.com Coin) is a marketing machine. But is this a good thing?

News for Cronos Group Stock (CRON)